Clinical Trial Update: Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating donor-derived BK virus-specific cytotoxic T cells for refractory BK infections in immunocompromised patients. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Polyomavirus Infection

Drugs mentioned

• BK virus-specific cytotoxic T cells (CTLs) (BK virus-specific cytotoxic T lymphocytes)

Snippet

Sponsor: New York Medical College | Conditions: Viral Infection, Primary Immune Deficiency Disorder | Phase 1, Phase 2 | Status: RECRUITING